AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Feb 19, 2013
30016_dirs_2013-02-19_ae24f77f-3c25-4480-857a-7223f34bef79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-02-14
Reporting Person: POWERS JOHNNY D (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-14 | Common Stock | M | 258 | — | Acquired | 4466 | Direct |
| 2013-02-14 | Common Stock | M | 242 | — | Acquired | 4708 | Direct |
| 2013-02-14 | Common Stock | M | 375 | — | Acquired | 5083 | Direct |
| 2013-02-14 | Common Stock | M | 509 | — | Acquired | 5592 | Direct |
| 2013-02-14 | Common Stock | F | 482 | $91.68 | Disposed | 5110 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-14 | Non-Qualified Stock Option (right to buy) | $91.68 | A | 13018 | Acquired | 2020-02-13 | Common Stock (13018) | Direct |
| 2013-02-14 | Incentive Stock Option (right to buy) | $91.68 | A | 1090 | Acquired | 2020-02-13 | Common Stock (1090) | Direct |
| 2013-02-14 | Restricted Stock Unit | $ | A | 1363 | Acquired | Common Stock (1363) | Direct | |
| 2013-02-14 | Restricted Stock Unit | $ | M | 258 | Disposed | Common Stock (258) | Direct | |
| 2013-02-14 | Restricted Stock Unit | $ | M | 242 | Disposed | Common Stock (242) | Direct | |
| 2013-02-14 | Restricted Stock Unit | $ | M | 375 | Disposed | Common Stock (375) | Direct | |
| 2013-02-14 | Restricted Stock Unit | $ | M | 509 | Disposed | Common Stock (509) | Direct |
Footnotes
F1: Includes 41 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2012.
F2: Grant of options to buy shares of common stock becomes exercisable as to 2,822 shares on 02/14/2014, 02/14/2015 and 02/14/2016, 2,821 shares on 02/14/2017, and the remaining 1,731 shares on 02/14/2018.
F3: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2018) of the grant.
F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.
F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.